M·CAM is now a Corporate Sponsor of Big Blue Sky Event

Date:  Tue, 2015-09-15

We here at M·CAM are proud to be a corporate sponsor of Big Blue Sky. Co-Founded by Dr Christine McDougall and Lou and Iain McGregor, Big Blue Sky is about listening, collaboration and taking inspired action to reframe the ”˜story’ of the Gold Coast and position it as a global example in Intelligence, IT and Innovation.

Head over to Big Blue Sky to read more about who they are and get inspired by their movement.

Future-Dreaming Documentary wins International Awards of Excellence

Date:  Fri, 2015-09-11

Congratulations to everyone involved in the new Documentary – Future-Dreaming on winning the International Award of Excellence. This is just the beginning of something amazing. What a success the first few showings were in Australia. Future-Dreaming was chosen along with other great films for this award. Congratulations to everyone.

To see the entire list of winners please visit – http://internationalfilmfestivals.org/IFFPIE/winners.htm

Dr. David E. Martin in Business News Western Australia

Date:  Tue, 2015-09-08

David Martin is the new Leader in Residence for Leadership WA – “As a now leader in residence what I’m going to suggest is that I may have a couple defibrillator paddles to put on this corpse and wake this thing up.” – Dr. Martin

Please continue reading HERE

David Martin to be Keynote Speaker at Big Blue Sky Event in November

Date:  Tue, 2015-08-25

M·CAM Founder Dr. David Martin will be one of 3 Keynote speakers at the Gold Coast’s Creativity and Innovation Festival – Big Blue Sky Event November 4-6.

“Big Blue Sky will bring together the world’s most coveted game-changers in visionary thinking, the UK’s most respected digital leaders, the smartest minds of the Gold Coast and the students lighting the way of our future.”

For more information please visit their website – Big Blue Sky Event and stay current with updates as the time closes in via our Facebook and Twitter

The Insight interviews Hannah Leonie Prinzler about The Patent Wars Documentary featuring Dr. David E. Martin

Date:  Tue, 2015-08-18

Hannah Leonie Prinzler gives an amazing interview about her Documentary – The Patent Wars –

Click HERE to read the article.

Dr. David Martin’s interview is live on SoundCloud

Date:  Mon, 2015-08-17

Listen to Dr. Martin expand on the who, what and how the Future Dreaming Documentary came about.

Putting It All Together – By: David E. Martin

Date:  Mon, 2015-08-10

M·CAM Inc. is an enterprise explicitly committed to the global alignment of innovation and efficient, integral capital. Ask the average person about M·CAM and, if they know about it at all, they will usually describe one facet of the entity that has successfully transformed the world’s view of intangible assets in economic systems. “Make it simple,” is the refrain I hear about the world. Put it in “plain English” please.

Please click HERE to continue reading!

M·CAM Founder Dr. David Martin Stars in a new documentary called – Future Dreaming

Date:  Mon, 2015-08-03

Future Dreaming is a remarkable documentary that will challenge the way you think about humanity. The film explores the narratives that drive our economic, social and political thinking and offers a new way of understanding the Human Condition.

Watch all three Trailers:

RUSSELL OKUNG – Betting on Myself

Date:  Mon, 2015-07-20

Our good friend Russell Okung was published in an Article “Betting on Myself”

“The fact of the matter is that even if the agent-player relationship is a close, heartfelt, personal one, it’s still founded on one thing: money.” – Russell Okung

Read the entire article HERE

House Judiciary Committee Approves Goodlatte Patent Reform Bill by Overwhelming, Bipartisan Vote

Date:  Thu, 2015-06-11

Washington, D.C. – The House Judiciary Committee today approved the Innovation Act (H.R. 9) by an overwhelming vote of 24-8. This bipartisan bill takes steps to combat the ever increasing problem of abusive patent litigation. The legislation addresses abusive practices taking place in our courts.

House Judiciary Committee Chairman and chief sponsor of the Innovation Act Bob Goodlatte (R-Va.), praised today’s Committee vote.

Chairman Goodlatte: “At its core, abusive patent litigation is a drag on our economy and stifles innovation. It is a problem that impacts businesses and industries of all types and the jobs of the people who work for them, from the tech sector to the hospitality industry and even grocery stores. Everyone from independent inventors, to start-ups, to mid-and large-sized businesses face this constant threat. The tens of billions of dollars squandered on settlements and litigation expenses associated with abusive patent suits represent truly wasted capital – capital that could have been used to create new jobs, fund research and development, and create new innovations and technologies.

“The Innovation Act takes the necessary steps to address abusive patent litigation, while protecting legitimate property rights. Specifically, the legislation targets abusive behavior rather than specific entities, preserves valid patent enforcement tools, preserves patent property rights, promotes invention by independents and small businesses, and strengthens the overall patent system.”

Key Components of the Innovation Act:

Targets Abusive Patent Litigation: The bill targets abusive patent litigation behavior and not specific entities with the goal of preventing individuals from taking advantage of gaps in the system to engage in litigation extortion. It does not attempt to eliminate valid patent litigation.

Protects the Patent System: This legislation does not diminish or devalue patent rights in any way.

Increases Transparency: This legislation requires greater transparency in patent litigation and requires parties to explain exactly why they are suing a business or individual. Requiring parties to do a bit of due diligence up front before filing an infringement suit is just plain common sense. It not only reduces litigation expenses, but saves the court’s time and resources. Greater transparency and information is a good thing and it makes our patent system stronger.

Prevents Extortion: The legislation prevents any one party in a patent lawsuit from unilaterally racking up extreme litigation costs for another party in an attempt to force a dubious settlement.

Provides Greater Clarity: The legislation provides for more clarity surrounding initial discovery, case management, joinder and the common law doctrine of customer stays. The bill works hand-in-hand with the procedures and practices of the Judicial Conference and the courts.

Small Business Education: The bill provides for small business education and outreach by the U.S. Patent and Trademark Office.

Places Reasonable Limits on Venue in Patent Cases: Restores Congress’s intent that patent infringement suits only be brought in judicial districts that have some reasonable connection to the dispute. Since 1897, Congress has regulated the venue in which patent actions may be brought. These limits protect parties against the burden and inconvenience of litigating patent lawsuits in districts that are remote from any of the underlying events in the case. In 1990 the U.S. Court of Appeals for the Federal Circuit “reinterpreted” that statute in a way that robbed it of all effect. The Innovation Act corrects the Federal Circuit’s error, and restores the congressional purpose of placing some reasonable limits on the venue where a patent action may be brought.

Reduces Unnecessary, Expensive Discovery: Requires that courts stay discovery in a patent case when a motion to dismiss or a motion to transfer has been filed. This will help parties avoid expensive, wasteful discovery that might otherwise be used as leverage by patent trolls looking for a quick settlement when a case can be resolved quickly and early.

VIDEO: Learn more about the importance of protecting and promoting American innovation by curbing abusive patent litigation by clicking HERE

M·CAM releases Patently Obvious® on How Attractive is Chimerix

Date:  Wed, 2015-06-10

M·CAM releases Patently Obvious® on How Attractive is Chimerix

While Chimerix’s fully owned patent portfolio is fairly small, a number of licensing agreements have allowed the company to develop beyond its own proprietary technology. Combining in-house and licensed patents gives Chimerix a strong exclusivity position if its CMX001 and CMX157 candidates pass through clinical trials. With no glaring prior art problems and strong third-party interest in its technology, the market may be overweighting Chimerix’s IP risk. M·CAM believes the company’s IP risk is lower than industry average, which should allow for a clean product launch and make Chimerix an attractive acquisition target for Gilead, Novartis, and other large pharma players.

M·CAM’s Patently Obvious® is a report providing visibility into potentially unconsidered alternatives, including art in the public domain, to patent holdings across a variety of technology areas.

M·CAM is a global, full-service intellectual property and rights (IP&R) and intangible asset financial services firm. We provide the technical and financial systems that allow public and private markets to use IP&R and IA for regulated transactions in banking, securities, insurance, and public innovation investment and technology procurement. From our pioneering work in creating the world’s first standards-based innovation collateralization financial products for banking and securities to our work in grassroots innovator enablement and patent quality assurance programs, M·CAM provides the mechanism to balance the interests of public and commercial sectors to support and build thriving economies.

The M·CAM Patently Obvious® on How Attractive is Chimerix can be found HERE